Back
Cleveland-Cliffs 10K Form
Sell
45
CLF
Cleveland-Cliffs
Last Price:
18.33
Seasonality Move:
2.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-07-28 | 10Q | CLF/Cleveland-Cliffs Quarterly |
2021-04-28 | 10Q | CLF/Cleveland-Cliffs Quarterly |
2021-02-26 | 10K | CLF/Cleveland-Cliffs Annual |
2020-10-23 | 10Q | CLF/Cleveland-Cliffs Quarterly |
2020-07-30 | 10Q | CLF/Cleveland-Cliffs Quarterly |
2020-05-11 | 10Q | CLF/Cleveland-Cliffs Quarterly |
Receive CLF News And Ratings
See the #1 stock for the next 7 days that we like better than CLF
CLF Financial Statistics
Sales & Book Value
Annual Sales: | $22.99B |
---|---|
Cash Flow: | $262M |
Price / Cash Flow: | 6.49 |
Annual Sales: | $15.18 |
Price / Book: | 1.21 |
Profitability
EPS (TTM): | 2.51000 |
---|---|
Net Income (TTM): | $1.34B |
Gross Margin: | $2.52B |
Return on Equity: | 20.01% |
Return on Assets: | 6.87% |
Cleveland-Cliffs Earnings Forecast
Key Cleveland-Cliffs Financial Ratios
- The Gross Profit Margin over the past 39 years for CLF is 10.95%.
- The Selling, General & Administrative Expenses for CLF have been equal to 2.02% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 20.67% of Operating Income.
- The Net Earning history of CLF is 5.81% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 21 years.
Cleveland-Cliffs Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Steel |
Sector: | Basic Materials |
Current Symbol: | CLF |
CUSIP: | 185899 |
Website: | clevelandcliffs.com |
Debt
Debt-to-Equity Ratio: | 0.55 |
---|---|
Current Ratio: | 2.09 |
Quick Ratio: | 0.56 |
Price-to-Earnings
Trailing P/E Ratio: | 7.19 |
---|---|
Forward P/E Ratio: | 7.05 |
CLF Technical Analysis vs Fundamental Analysis
Sell
45
Cleveland-Cliffs (CLF)
is a Sell
Is Cleveland-Cliffs a Buy or a Sell?
-
Cleveland-Cliffs stock is rated a Sell
The current Cleveland-Cliffs [CLF] share price is $18.33. The Score for CLF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.